CollPlant Biotechnologies Ltd. (CLGN)
0.3203
-0.02
(-6.70%)
USD |
NASDAQ |
Sep 03, 16:00
0.33
+0.01
(+3.03%)
After-Hours: 20:00
CollPlant Biotechnologies Total Assets (Quarterly) : 9.183M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 9.183M |
| December 31, 2025 | 10.78M |
| September 30, 2025 | 14.09M |
| June 30, 2025 | 17.44M |
| March 31, 2025 | 17.21M |
| December 31, 2024 | 18.71M |
| September 30, 2024 | 22.44M |
| June 30, 2024 | 26.57M |
| March 31, 2024 | 30.29M |
| December 31, 2023 | 34.13M |
| September 30, 2023 | 37.56M |
| June 30, 2023 | 41.57M |
| March 31, 2023 | 35.76M |
| December 31, 2022 | 37.77M |
| September 30, 2022 | 40.56M |
| June 30, 2022 | 44.41M |
| March 31, 2022 | 48.72M |
| December 31, 2021 | 51.22M |
| September 30, 2021 | 53.63M |
| June 30, 2021 | 55.02M |
| March 31, 2021 | 56.63M |
| December 31, 2020 | 10.84M |
| September 30, 2020 | 12.78M |
| June 30, 2020 | 10.95M |
| March 31, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | 12.87M |
| June 30, 2019 | 9.547M |
| March 31, 2019 | 11.64M |
| December 31, 2018 | 9.121M |
| September 30, 2018 | 6.178M |
| June 30, 2018 | 6.242M |
| March 31, 2018 | 7.039M |
| December 31, 2017 | 8.078M |
| September 30, 2017 | 4.476M |
| June 30, 2017 | 3.403M |
| March 31, 2017 | 3.974M |
| December 31, 2016 | 3.750M |
| September 30, 2016 | 4.945M |
| June 30, 2016 | 5.505M |
| March 31, 2016 | 3.858M |
| December 31, 2015 | 3.477M |
| September 30, 2015 | 4.704M |
| June 30, 2015 | 2.849M |
| March 31, 2015 | 3.471M |
| December 31, 2014 | 4.358M |
| September 30, 2014 | 5.420M |
| June 30, 2014 | 6.549M |
| March 31, 2014 | 7.352M |
| December 31, 2013 | 8.722M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 183.47M |
| Perspective Therapeutics, Inc. | 392.02M |
| MiMedx Group, Inc. | 281.00M |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.297M |
| Shareholders Equity (Quarterly) | 4.886M |
| Debt to Equity Ratio | 0.5422 |
| Current Ratio | 2.268 |
| Net Debt Paydown Yield | 1.12% |